Finally, in group IV (n = 11; 14.7%; 9 men; age: 75.6 ± 1.0) further tau pathologies compatible with primary tauopathies or ARTAG were observed with various degree of neurofibrillary degeneration (four cases Braak stage II and seven stage III). The gene discussed is MAPT; the disease is tauopathy.